Gene Therapy Cured ‘Bubble Boys’

An experimental gene therapy has cured eight infants with the immune system deficiency known as Bubble Boy Disease.

'It was the Moors.' / Image: Fox
"It was the Moors." / Image: Fox

Chances are the only “Bubble Boy” you’re familiar with was arguing that the Moors invaded Spain in 8th Century. Or was it the Moops? Regardless, a recent Bloomberg article contained good news for bubble boys everywhere: a cure has been found! Bubble Boy Disease refers to an immune-system deficiency so severe that children were at one time kept in total isolation for fear that any attack on the immune system could be lethal.

A team of researchers at St. Jude Children’s Research Hospital in Memphis has developed a personalized gene therapy treatment to correct the genetic issue. It proved successful in eight male infants who are now toddlers who are leading normal lives. St. Jude licensed the therapy to Mustang Bio Inc., a small biopharmaceutical company that plans to file for global regulatory approval by the end of 2021.

Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report